Chemotherapy in Treating Patients Who Have Metastatic Prostate Cancer

NCT00003343 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

525

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: endocrine-modulating drug therapy
DRUG: mitoxantrone hydrochloride
DRUG: prednisone
DRUG: prinomastat

Sponsor

Pfizer